Cargando…
Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways
The selection of 3΄ splice sites (3΄ss) is an essential early step in mammalian RNA splicing reactions, but the processes involved are unknown. We have used single molecule methods to test whether the major components implicated in selection, the proteins U2AF35 and U2AF65 and the U2 snRNP, are able...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389562/ https://www.ncbi.nlm.nih.gov/pubmed/27683217 http://dx.doi.org/10.1093/nar/gkw860 |
_version_ | 1782521292655689728 |
---|---|
author | Chen, Li Weinmeister, Robert Kralovicova, Jana Eperon, Lucy P. Vorechovsky, Igor Hudson, Andrew J. Eperon, Ian C. |
author_facet | Chen, Li Weinmeister, Robert Kralovicova, Jana Eperon, Lucy P. Vorechovsky, Igor Hudson, Andrew J. Eperon, Ian C. |
author_sort | Chen, Li |
collection | PubMed |
description | The selection of 3΄ splice sites (3΄ss) is an essential early step in mammalian RNA splicing reactions, but the processes involved are unknown. We have used single molecule methods to test whether the major components implicated in selection, the proteins U2AF35 and U2AF65 and the U2 snRNP, are able to recognize alternative candidate sites or are restricted to one pre-specified site. In the presence of adenosine triphosphate (ATP), all three components bind in a 1:1 stoichiometry with a 3΄ss. Pre-mRNA molecules with two alternative 3΄ss can be bound concurrently by two molecules of U2AF or two U2 snRNPs, so none of the components are restricted. However, concurrent occupancy inhibits splicing. Stoichiometric binding requires conditions consistent with coalescence of the 5΄ and 3΄ sites in a complex (I, initial), but if this cannot form the components show unrestricted and stochastic association. In the absence of ATP, when complex E forms, U2 snRNP association is unrestricted. However, if protein dephosphorylation is prevented, an I-like complex forms with stoichiometric association of U2 snRNPs and the U2 snRNA is base-paired to the pre-mRNA. Complex I differs from complex A in that the formation of complex A is associated with the loss of U2AF65 and 35. |
format | Online Article Text |
id | pubmed-5389562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53895622017-04-24 Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways Chen, Li Weinmeister, Robert Kralovicova, Jana Eperon, Lucy P. Vorechovsky, Igor Hudson, Andrew J. Eperon, Ian C. Nucleic Acids Res RNA The selection of 3΄ splice sites (3΄ss) is an essential early step in mammalian RNA splicing reactions, but the processes involved are unknown. We have used single molecule methods to test whether the major components implicated in selection, the proteins U2AF35 and U2AF65 and the U2 snRNP, are able to recognize alternative candidate sites or are restricted to one pre-specified site. In the presence of adenosine triphosphate (ATP), all three components bind in a 1:1 stoichiometry with a 3΄ss. Pre-mRNA molecules with two alternative 3΄ss can be bound concurrently by two molecules of U2AF or two U2 snRNPs, so none of the components are restricted. However, concurrent occupancy inhibits splicing. Stoichiometric binding requires conditions consistent with coalescence of the 5΄ and 3΄ sites in a complex (I, initial), but if this cannot form the components show unrestricted and stochastic association. In the absence of ATP, when complex E forms, U2 snRNP association is unrestricted. However, if protein dephosphorylation is prevented, an I-like complex forms with stoichiometric association of U2 snRNPs and the U2 snRNA is base-paired to the pre-mRNA. Complex I differs from complex A in that the formation of complex A is associated with the loss of U2AF65 and 35. Oxford University Press 2017-02-28 2016-09-28 /pmc/articles/PMC5389562/ /pubmed/27683217 http://dx.doi.org/10.1093/nar/gkw860 Text en © The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RNA Chen, Li Weinmeister, Robert Kralovicova, Jana Eperon, Lucy P. Vorechovsky, Igor Hudson, Andrew J. Eperon, Ian C. Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title | Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title_full | Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title_fullStr | Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title_full_unstemmed | Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title_short | Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways |
title_sort | stoichiometries of u2af35, u2af65 and u2 snrnp reveal new early spliceosome assembly pathways |
topic | RNA |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389562/ https://www.ncbi.nlm.nih.gov/pubmed/27683217 http://dx.doi.org/10.1093/nar/gkw860 |
work_keys_str_mv | AT chenli stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT weinmeisterrobert stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT kralovicovajana stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT eperonlucyp stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT vorechovskyigor stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT hudsonandrewj stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways AT eperonianc stoichiometriesofu2af35u2af65andu2snrnprevealnewearlyspliceosomeassemblypathways |